Anti-NGF monoclonal antibody, clone KLiOHG-3 [Biotin]

Neurotrophins represent a family of small polypeptides that regulate biological processes by binding to specific receptors. The nerve growth factor (NGF) serves as the main regulator of neuronal survival systems along with cellular differentiation and axonal pathfinding regulation throughout both peripheral and central nervous system structures. The NGF protein complex remains structurally conserved through the interaction of one β-subunit with two α-subunits and two γ-subunits which connect through non-covalent bonds. The β-NGF subunit functions biologically as two 118-amino acid chains form a homodimer connected by disulfide bonds which create its unique functional domain essential for neurotrophic activity.

NGF achieves its biological functions by interacting with two distinct receptor types: The high-affinity TrkA receptor collaborates with the low-affinity p75NTR receptor to control NGF functions. Upon ligand attachment TrkA's kinase function becomes active which sequentially turns on the PI3K/Akt and MAPK/ERK signaling pathways to boost neuron survival and adjust synaptic plasticity processes. The development process involves NGF moving retrogradely to control gene expression which directs sensory and sympathetic neurons to their target innervation. This mechanism preserves essential basal forebrain cholinergic neurons for learning and memory during adulthood and controls immune functions including T/B-lymphocyte multiplication and immunoglobulin secretion as well as mast cell degranulation which are related to asthma and inflammatory bowel disease. p75NTR acts as a transmembrane glycoprotein within the TNF receptor superfamily that binds all neurotrophins. The receptor functions to control TrkA signaling pathways and regulate cell migration alongside apoptosis, neurotransmitter retrograde transport and axonal growth processes. p75NTR exhibits dual signaling: By partnering with TrkA p75NTR boosts neuronal survival while it can initiate apoptosis by itself when TrkA is not present. When p75NTR partners with TrkA it enhances ligand-binding affinity and promotes axonal growth but activates cell death through caspase pathways when expressed alone. Cellular responses rely on the interaction between TrkA and p75NTR signaling which regulates the balance between cell survival mechanisms and apoptotic pathways based on the surrounding context.

Figure 1. Illustration showing NGF related upstream and downstream pathways
(Source: Mufson EJ, et al. 2019)

NGF triggers inflammatory and neuropathic pain through TRPV1 channel upregulation and calcium influx enhancement which leads to substance P/CGRP release that results in peripheral and central sensitization. Osteoarthritis patients experience significant pain relief from the anti-NGF monoclonal antibody which interrupts nociceptive signaling pathways. Research shows that Alzheimer's disease patients with reduced NGF levels experience basal forebrain cholinergic neuron degeneration alongside cognitive decline yet preclinical studies indicate direct brain administration of NGF improves memory functions in Alzheimer's disease models. However, optimizing delivery methods (e.g., intranasal routes) remains critical for clinical translation. Research into Parkinson's disease shows that NGF protects dopaminergic neurons which may delay motor dysfunction progression. The latest cancer research demonstrates that NGF-TrkA signaling encourages sensory nerve invasion in gastric and colorectal tumors through the CGRP-RAMP1/CALCR pathway which speeds up tumor development while presenting new targets to block neuro-tumor communication. This mechanistic insight advances strategies targeting nerve-cancer interactions to complement conventional therapies.

Anti-nerve growth factor monoclonal antibody